web analytics
14.6 C
Munich
Sunday, September 25, 2022

REMSleep Holdings Inc (OTCMKTS: RMSL) Getting Noticed as Co Fills Orders for its CPAP MASKs and Looks to get its new DeltaWave CPAP Approved

REMSleep Holdings Inc (OTCMKTS: RMSL) is looking for a breakout out of its current trading range as there is currently a significant CPAP shortage underway. The Company is starting to get noticed as its builds out its 10,000 square foot office warehouse in Largo, Florida that is recently leased. The Company is aware that they will probably need to rent a much larger shipping warehouse later this year if the current CPAP shortage continues. The new facility will help the company in its push to create more CPAP devices to alleviate the ongoing shortage. REMSleep plans to grow its staff as well as engage in a strong marketing campaign and website revamp for its product. The company is currently working with its securities attorney to gather information and complete an application to apply for OTCQB tier designation.  

This may help RMSL get back over the $0.04 level where it traded back in 2021. Recently securing an agreement with an overseas manufacturer for the import of 1500 nasal CPAP machines. The devices will be ready in mid-April, with a large quantity of additional units being delivered in the months to follow. CPAP machines is also turning into a hot industry; according to online studies, 50 to 70 million adults in the United States have a sleep disorder and an estimated 22 million Americans are living with moderate to severe sleep apnea. With the current shortage of CPAP devices, the quality of sleep for so many individuals are being affected.  

REMSleep Holdings Inc (OTCMKTS: RMSL) is a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive Sleep Apnea patients. Our focus is primarily designing and manufacturing devices and products for the treatment of Sleep Apnea and other respiratory conditions. With over 30 years of collective experience in CPAP therapy, the RemSleep team has extensive knowledge and understanding of CPAP and the challenges of patient compliance. We diligently strive for our products to make the difference and improve the condition of those suffering from Sleep Apnea. 

The Company makes a number of products related to apnea including its FDA approved CPAP Masks which stop people from snoring while sleeping; REMSleep recently negotiated an agreement with an overseas manufacturer for the import of 1500 nasal CPAP machines. The devices will be ready in mid-April, with a large quantity of additional units being delivered in the months to follow. The United States has been experiencing a major shortage of availability for CPAP machines. This occurrence has been due to a recent recall from a well-known manufacturer, as well as global supply disruption and congestion, leaving many suffering from sleep apnea, quite alarmed. 

  To Find out the inside Scoop on RMSL Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

RMSL

REMSleep is currently building out a 10,000 square foot office warehouse in Largo, Florida that is recently leased. The Company is aware that they will probably need to rent a much larger shipping warehouse later this year if the current CPAP shortage continues. The new facility will help the company in its push to create more CPAP devices to alleviate the ongoing shortage. To accommodate for the expected growth. The company is also looking to grow its staff as well as engage in a strong marketing campaign and website revamp for its product. 

The NEW DeltaWave CPAP MASK is Uniquely Different proving a more comfortable anti snoring mask that allows for normal breathing. Recently submitting their 510k for the device, the Company worked hard to complete all the tests required by the FDA however they failed the retest due to what is believed to be a faulty analysis by the testing company. The company believes they can narrow down the exact part of the device that is failing the test and quickly resolve this matter. They have committed to a new third party lab to redo the test and provide results within the next few weeks. 

REMSleep operates in a hot industry; according to online studies, 50 to 70 million adults in the United States have a sleep disorder and an estimated 22 million Americans are living with moderate to severe sleep apnea. With the current shortage of CPAP devices, the quality of sleep for so many individuals are being affected. 

 For More on RMSL Subscribe Right Now!

Currently trading at a 25,426,385-market valuation RMSL has 1,452,936,313 outstanding shares and a strong balance sheet with $2.3 million in the treasury and manageable debt of just over $1 million. The Company is currently focused on filling orders for its FDA approved CPAP Masks as well as getting its new DeltaWave CPAP MASK approved by the FDA. The Company is optimistic they will be met with success, CEO Tom Wood recently said: “We are optimistic about our strategies going forward, to bring in revenues to our company, as well as aiming to submit our 510k using the extension granted through the FDA.” We will be updating on RMSL when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with RMSL.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in RMSL either long or short and we have not been compensated for this article

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.